Safety and Allele-Specific Immunogenicity of a Malaria Vaccine in Malian Adults: Results of a Phase I Randomized Trial

OBJECTIVES: The objectives were to evaluate the safety, reactogenicity, and allele-specific immunogenicity of the blood-stage malaria vaccine FMP1/AS02A in adults exposed to seasonal malaria and the impact of natural infection on vaccine-induced antibody levels. DESIGN: We conducted a randomized, do...

Descripción completa

Detalles Bibliográficos
Autores principales: Thera, Mahamadou A, Doumbo, Ogobara K, Coulibaly, Drissa, Diallo, Dapa A, Sagara, Issaka, Dicko, Alassane, Diemert, David J, Heppner, D. Gray, Stewart, V. Ann, Angov, Evelina, Soisson, Lorraine, Leach, Amanda, Tucker, Kathryn, Lyke, Kirsten E, Plowe, Christopher V
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851722/
https://www.ncbi.nlm.nih.gov/pubmed/17124530
http://dx.doi.org/10.1371/journal.pctr.0010034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851722/
https://www.ncbi.nlm.nih.gov/pubmed/17124530
http://dx.doi.org/10.1371/journal.pctr.0010034

Ejemplares similares